287 related articles for article (PubMed ID: 16176851)
1. Potential for broad-spectrum protection against feline calicivirus using an attenuated myxoma virus expressing a chimeric FCV capsid protein.
McCabe VJ; Spibey N
Vaccine; 2005 Nov; 23(46-47):5380-8. PubMed ID: 16176851
[TBL] [Abstract][Full Text] [Related]
2. Assembly of feline calicivirus-like particle and its immunogenicity.
Di Martino B; Marsilio F; Roy P
Vet Microbiol; 2007 Feb; 120(1-2):173-8. PubMed ID: 17126499
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein.
McCabe VJ; Tarpey I; Spibey N
Vaccine; 2002 Jun; 20(19-20):2454-62. PubMed ID: 12057600
[TBL] [Abstract][Full Text] [Related]
4. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges.
Poulet H; Brunet S; Leroy V; Chappuis G
Vet Microbiol; 2005 Mar; 106(1-2):17-31. PubMed ID: 15737470
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.
Rong S; Lowery D; Floyd-Hawkins K; King V
Virus Res; 2014 Aug; 188():60-7. PubMed ID: 24685673
[TBL] [Abstract][Full Text] [Related]
6. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease.
Huang C; Hess J; Gill M; Hustead D
J Feline Med Surg; 2010 Feb; 12(2):129-37. PubMed ID: 19836282
[TBL] [Abstract][Full Text] [Related]
7. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
[TBL] [Abstract][Full Text] [Related]
8. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.
Schwantes A; Truyen U; Weikel J; Weiss C; Löchelt M
J Virol; 2003 Jul; 77(14):7830-42. PubMed ID: 12829823
[TBL] [Abstract][Full Text] [Related]
9. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
Scott FW; Geissinger CM
Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
[TBL] [Abstract][Full Text] [Related]
10. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
[TBL] [Abstract][Full Text] [Related]
11. Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.
Ohe K; Sakai S; Takahasi T; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Ishikawa Y; Taneno A
Vet Res Commun; 2007 May; 31(4):497-507. PubMed ID: 17225086
[TBL] [Abstract][Full Text] [Related]
12. Feline calicivirus strains isolated in Italy.
Rinaldo D; Foti M; Bottari T; Fisichella V; Buonavoglia D
Pol J Vet Sci; 2008; 11(4):359-61. PubMed ID: 19227135
[TBL] [Abstract][Full Text] [Related]
13. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens.
Kanellos T; Sutton DJ; Salisbury CF; Chalmers WS
J Feline Med Surg; 2008 Aug; 10(4):346-54. PubMed ID: 18448375
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a highly virulent feline calicivirus and attenuation of this virus.
Rong S; Slade D; Floyd-Hawkins K; Wheeler D
Virus Res; 2006 Dec; 122(1-2):95-108. PubMed ID: 16950539
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates.
Hohdatsu T; Sato K; Tajima T; Koyama H
J Vet Med Sci; 1999 Mar; 61(3):299-301. PubMed ID: 10331208
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates.
Porter CJ; Radford AD; Gaskell RM; Ryvar R; Coyne KP; Pinchbeck GL; Dawson S
J Feline Med Surg; 2008 Feb; 10(1):32-40. PubMed ID: 17720588
[TBL] [Abstract][Full Text] [Related]
17. Temporally separated feline calicivirus isolates do not cluster phylogenetically and are similarly neutralised by high-titre vaccine strain FCV-F9 antisera in vitro.
Smith SL; Afonso MM; Pinchbeck GL; Gaskell RM; Dawson S; Radford AD
J Feline Med Surg; 2020 Jun; 22(6):602-607. PubMed ID: 31411533
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccination against feline calicivirus infection using a plasmid encoding the mature capsid protein.
Sommerville LM; Radford AD; Glenn M; Dawson S; Gaskell CJ; Kelly DF; Cripps PJ; Porter CJ; Gaskell RM
Vaccine; 2002 Mar; 20(13-14):1787-96. PubMed ID: 11906766
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine.
Scott FW
Am J Vet Res; 1977 Feb; 38(2):229-34. PubMed ID: 190925
[TBL] [Abstract][Full Text] [Related]
20. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats.
Lappin MR; Andrews J; Simpson D; Jensen WA
J Am Vet Med Assoc; 2002 Jan; 220(1):38-42. PubMed ID: 12680445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
